The firings over the weekend included about 20 employees who were part of the FDA’s office of neurological and physical medicine devices, responsible for reviewing clinical trial applications of brain implant technology, including Neuralink, two anonymous sources told Reuters.
The sources said they did not believe the employees assigned to review Neuralink were specifically targeted in the wave of firings.
The sackings come amid a larger purge of about 5,200 workers in the U.S. Department of Health and Human Services announced Friday, including the Centers for Medicare and Medicaid Services, Centers for Disease Control and Prevention, and the National Institutes of Health. The cuts impacted probationary employees, or those with less than two years of experience who don’t have the same legal protections as senior workers. The anonymous sources told Reuters the letters of dismissal cited performance issues, despite the fired employees receiving positive feedback on reviews several weeks ago.